Charles River Laboratories International, Inc. (CRL)
166.79
-4.44
(-2.59%)
USD |
NYSE |
Apr 28, 16:00
166.71
-0.08
(-0.05%)
Pre-Market: 20:00
Charles River Laboratories International EPS Diluted (Quarterly) : -5.619 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 2.990 |
| Centene Corp. | -2.240 |
| Insulet Corp. | 1.441 |
| Thermo Fisher Scientific, Inc. | 4.43 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -276.29M |
| Revenue (Quarterly) | 994.23M |
| Total Expenses (Quarterly) | 1.271B |
| Enterprise Value | 10.69B |
| Gross Profit Margin (Quarterly) | 30.96% |
| Profit Margin (Quarterly) | -27.79% |
| Earnings Yield | -1.77% |
| Operating Earnings Yield | 6.04% |
| Normalized Earnings Yield | 2.200 |